ALS News | ALS Therapy Development Institute

Your support fuels our research to #EndALS! Donate Now

ALS Research News

Wednesday, November 30, 2022

What are Pharmacokinetic and Pharmacodynamic Studies?

For anyone who follows drug development closely, the terms pharmacodynamics (PD) and pharmacokinetic

Friday, October 21, 2022

2022 ALS TDI Summit Presents Updates on Promising Research and Potential Treatments

Speakers included ALS TDI scientists and leaders from across the ALS space, as well as Leadership Awards honoring exemplary members of the community.

Friday, October 21, 2022

How to Find, Read, and Understand a Research Paper – Even if You’re not a Scientist

Dr. Kyle Denton, Director of Cell Biology at ALS TDI, on how non-scientists can better understand scientific research papers.

From trial readouts to news from our lab, you can find all of the latest ALS research news here.

More ALS Research News

COVID-19 Updates

Thursday, June 10, 2021

ALS TDI Welcomes Back Tours to our New Lab

Tuesday, June 2, 2020

How ALS TDI is Moving Forward with Phase 1 Reopening of Lab

Friday, May 29, 2020

ALS TDI Researchers Keep Essential Animal Experiments Running in the Lab

More COVID-19 Updates

ALS TDI Community Blog

Friday, November 18, 2022

Understanding the Different Types of Therapeutics

When looking at treatments in clinical trials for amyotrophic lateral sclerosis (ALS), you will encounter all these different types of potential treatments.

Friday, November 18, 2022

What is the ALSFRS-r?

In order to create a standardized way to track ALS disease progression, researchers have developed a questionnaire, the Revised ALS Functional Rating Scale (ALSFRS-r).

Thursday, November 17, 2022

Giving Tuesday 2022

Every year on GivingTuesday ALS TDI highlights different people in our community who have been affected by ALS, and who are sharing their stories to help advance treatments.

Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Wednesday, September 28, 2022

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research.

Tuesday, May 31, 2022

Eledon Announces Phase 2a Trial Results for Tegoprubart - a Drug Invented at ALS TDI

Tuesday, March 1, 2022

Tegoprubart: AT-1501’s New Name

AT-1501, a drug invented at the ALS Therapy Development Institute (ALS TDI) and being developed by Eledon Pharmaceuticals, has a new name: tegoprubart.

A complete list of press releases from the ALS Therapy Development Institute.

More ALS TDI Press Releases

Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!

Media Contact

We'd love to share our story with you. Speak to our team about our unique approach to end ALS.

marketing@als.net | 617.441.7200

ALS News & Stories